22 min listen
Updates from the 2021 ASH Meeting on Chronic Lymphocytic Leukemia with Dr Matthew Davids
Updates from the 2021 ASH Meeting on Chronic Lymphocytic Leukemia with Dr Matthew Davids
ratings:
Length:
41 minutes
Released:
Feb 2, 2022
Format:
Podcast episode
Description
Dr Matthew Davids from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent therapeutic advances in chronic lymphocytic leukemia presented at ASH 2021.
CME information and select publications here (http://www.researchtopractice.com/OncologyTodayPostASHCLL22).
CME information and select publications here (http://www.researchtopractice.com/OncologyTodayPostASHCLL22).
Released:
Feb 2, 2022
Format:
Podcast episode
Titles in the series (100)
Dr Tom Lynch on Adjuvant EGFR TKIs in Lung Cancer and COVID-19 in Seattle: Dr Tom Lynch comments on the current status of oncology research and data soon to be presented from a Phase III trial evaluating the EGFR TKI osimertinib as adjuvant therapy for patients with non-small cell lung cancer and EGFR tumor mutations. by Oncology Today with Dr Neil Love